Literature DB >> 24750534

Community care for the Elderly: Needs and Service Use Study (CENSUS): Who receives home care packages and what are the outcomes?

Lee-Fay Low1, Jennifer Fletcher1, Meredith Gresham2, Henry Brodaty1,3.   

Abstract

AIM: Investigate factors associated with waiting times for home care packages and outcomes for care recipients and carers.
METHOD: Analyses of data collected every four months for 12 months from 55 community-dwelling older adults eligible for government-subsidised packaged care and their carers.
RESULTS: Thirty of fifty-five participants were offered a package; they waited from one to 237 days. Baseline quality of life was higher for those offered a package than those not. Baseline care needs and unmet needs, neuropsychiatric symptoms, and cognitive decline did not predict offers. Package receipt compared to non-package receipt was associated with decreased carer burden over time but did not affect levels of unmet care needs, care needs or quality of life.
CONCLUSIONS: Being offered a home care package was not based on waiting time or unmet care needs. Reforms should include a transparent system of wait listing and prioritisation.
© 2014 ACOTA.

Entities:  

Keywords:  aged; health service for the aged; health service need and demand; home care service; needs assessment.

Mesh:

Year:  2014        PMID: 24750534     DOI: 10.1111/ajag.12155

Source DB:  PubMed          Journal:  Australas J Ageing        ISSN: 1440-6381            Impact factor:   2.111


  2 in total

1.  Adequate access to healthcare and added life expectancy among older adults in China.

Authors:  Lisha Hao; Xin Xu; Matthew E Dupre; Aimei Guo; Xufan Zhang; Li Qiu; Yuan Zhao; Danan Gu
Journal:  BMC Geriatr       Date:  2020-04-09       Impact factor: 3.921

2.  Urban-rural differences in the association between access to healthcare and health outcomes among older adults in China.

Authors:  Xufan Zhang; Matthew E Dupre; Li Qiu; Wei Zhou; Yuan Zhao; Danan Gu
Journal:  BMC Geriatr       Date:  2017-07-19       Impact factor: 3.921

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.